The triple-negative (ER-, PgR-, and HER2-negative) subtype of breast cancer was reported to have a poor prognosis compared to luminal (ER-positive and/or PgR-negative and HER2-negative) breast cancer [11]. This evidence concerns the gene ERBB2 and breast carcinoma.